Medical Condition News

RSS

Experts estimate the prevalence of breast cancer survivors in Canada

It was the information she couldn't find that led Amy Kirkham, an assistant professor in the University of Toronto's Faculty of Kinesiology & Physical Education (KPE), to her latest discovery.

3 Nov 2022

Political divide and public opinion influence racial disparities in COVID-19 mortality

Researchers at the University of Wisconsin-Madison and the University of California-Los Angeles investigated how political polarization in the United States (US) shaped the time-varying patterns of racial inequality in coronavirus disease 2019 (COVID-19) mortality since the onset of the pandemic.

3 Nov 2022

Effect of marital stress on heart attack recovery is detrimental

In a recent study soon to be presented at the American Heart Association (AHA) Scientific Sessions 2022*, researchers examined the adverse effects of marital stress (MS) on recovery from acute myocardial infarction (AMI).

2 Nov 2022

Many middle-aged adults unlikely to participate in dementia prevention clinical trials

Right now, drug companies and university-based teams are working urgently to find and test new medications that could prevent or slow the decline of brain function in older adults.

2 Nov 2022

Study suggests oral cephalosporins as safe, effective alternative for treating acute kidney infections

A new study led by Ochsner infectious diseases clinical pharmacist Kevin Lin, PharmD, was recently published in PLoS One, suggesting that oral cephalosporins are as safe and effective as the standard of care fluoroquinolones (FQs) for the treatment of acute kidney infections.

2 Nov 2022

Moderate to heavy drinking could increase the risk of stroke in young adults

People in their 20s and 30s who drink moderate to heavy amounts of alcohol may be more likely to have a stroke as young adults than people who drink low amounts or no alcohol, according to a study published in the November 2, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

2 Nov 2022

Study provides new set of targets for drug therapies to combat chronic inflammatory diseases

Innate lymphoid cells are a recently discovered family of white blood cells that reside in the skin, gastrointestinal tract, airways and other barrier tissues of the body.

2 Nov 2022

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs

An estimated 6.2 million Americans ages 65 and older are living with Alzheimer's disease. The national Alzheimer's Association predicts that number to grow to 13.8 million by 2060, barring the development of medical breakthroughs that would prevent, slow or cure the debilitating disease.

2 Nov 2022

Researchers corroborate the importance of exercise for cognitive function

Accumulating evidence finds that exercise can improve brain function and delay or prevent the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

2 Nov 2022

Contrastive learning model can detect lung damage in long-COVID patients

For patients dealing with lingering respiratory symptoms from the novel coronavirus, a chest X-ray can reveal only so much.

2 Nov 2022

Higher viscosity of extracellular fluid enhances cancer dissemination

New research findings show how higher viscosity, or resistance to flow, of the extracellular fluid that surrounds cells enables cancer cells to migrate more rapidly from a primary tumor to other sites in the body.

2 Nov 2022

3D model reveals how cadmium exposure may lead to congenital heart disease

Researchers have developed a three-dimensional model that shows how exposure to cadmium might lead to congenital heart disease.

2 Nov 2022

Personalized approach to kidney disease screening for T1D patients could enable earlier disease detection

Taking a personalized approach to kidney disease screening for people with type 1 diabetes (T1D) may reduce the time that chronic kidney disease goes undetected, according to a new analysis performed by the Epidemiology of Diabetes Interventions and Complications study group, which is funded by the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health.

2 Nov 2022

Memory: a revolutionary treatment for mental health disorders and neurodegeneration?

In this interview, we speak to Dr. Steve Ramirez about his latest neuroscience research that investigated the power of our memories.

2 Nov 2022

An optimal approach to treat femoropopliteal lesions

New research published in the Journal of the American College of Cardiology shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.

2 Nov 2022

Obesity management likely to improve the clinical outcome of MS

Carrying far too much weight when diagnosed with MS (multiple sclerosis) is linked to higher current and subsequent levels of disability within a relatively short period of time, finds research published online in the Journal of Neurology Neurosurgery & Psychiatry.

2 Nov 2022

Study identifies a root cause of chronic heart failure following a heart attack

A multi-institution study led by Rohan Dharmakumar, PhD, of Indiana University School of Medicine, has identified that iron drives the formation of fatty tissue in the heart and leads to chronic heart failure in about fifty percent of heart attack survivors.

1 Nov 2022

Researchers offer new insights into the neurobiological basis of autism spectrum disorders

Findings from a new study published in Cell Reports, involving a collaborative effort between researchers at the Luikart Laboratory at Dartmouth's Geisel School of Medicine and the Weston Laboratory at the University of Vermont, are providing further insight into the neurobiological basis of autism spectrum disorders (ASD) and pointing to possible treatments.

1 Nov 2022

Extensive European study finds very high rates of long-COVID

In a recent study published by the European Center for Disease Prevention and Control, researchers assessed the prevalence of post-coronavirus disease 2019 (COVID-19) condition symptoms.

1 Nov 2022

COVID-19 positive hearts may be safe for transplantation

A recent study soon to be presented at the American Heart Association (AHA) Scientific Sessions 2022* suggests that hearts from coronavirus disease 2019 (COVID-19)-positive (COVID-19+) donors may be safe for transplantation.

1 Nov 2022

Medical Condition News

Experts estimate the prevalence of breast cancer survivors in Canada

Political divide and public opinion influence racial disparities in COVID-19 mortality

Effect of marital stress on heart attack recovery is detrimental

Many middle-aged adults unlikely to participate in dementia prevention clinical trials

Study suggests oral cephalosporins as safe, effective alternative for treating acute kidney infections

Moderate to heavy drinking could increase the risk of stroke in young adults

Study provides new set of targets for drug therapies to combat chronic inflammatory diseases

First-of-its-kind computer model simulates a clinical trial evaluating two Alzheimer’s drugs

Researchers corroborate the importance of exercise for cognitive function

Contrastive learning model can detect lung damage in long-COVID patients

Higher viscosity of extracellular fluid enhances cancer dissemination

3D model reveals how cadmium exposure may lead to congenital heart disease

Personalized approach to kidney disease screening for T1D patients could enable earlier disease detection

Memory: a revolutionary treatment for mental health disorders and neurodegeneration?

An optimal approach to treat femoropopliteal lesions

Obesity management likely to improve the clinical outcome of MS

Study identifies a root cause of chronic heart failure following a heart attack

Researchers offer new insights into the neurobiological basis of autism spectrum disorders

Extensive European study finds very high rates of long-COVID

COVID-19 positive hearts may be safe for transplantation

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News